271 related articles for article (PubMed ID: 23701163)
1. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity.
Shih TY; Young TH; Lee HS; Hsieh CB; Hu OY
AAPS J; 2013 Jul; 15(3):753-62. PubMed ID: 23591749
[TBL] [Abstract][Full Text] [Related]
3. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of the bioactive natural product N-trans-Caffeoyldopamine on hepatotoxicity induced by isoniazid and rifampicin.
Wu ZR; Bai ZT; Sun Y; Chen P; Yang ZG; Zhi DJ; Li Y; Wang X; Du JJ; Yang R; Cui P; Zhang Y; Li HY
Bioorg Med Chem Lett; 2015 Nov; 25(22):5424-6. PubMed ID: 26410075
[TBL] [Abstract][Full Text] [Related]
5. Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity.
Nwidu LL; Teme RE
J Integr Med; 2018 Jul; 16(4):263-272. PubMed ID: 29776838
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.
Attri S; Rana SV; Vaiphei K; Sodhi CP; Katyal R; Goel RC; Nain CK; Singh K
Hum Exp Toxicol; 2000 Sep; 19(9):517-22. PubMed ID: 11204554
[TBL] [Abstract][Full Text] [Related]
7. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
Wang C; Fan RQ; Zhang YX; Nie H; Li K
World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
[TBL] [Abstract][Full Text] [Related]
8. Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats.
Pal R; Vaiphei K; Sikander A; Singh K; Rana SV
World J Gastroenterol; 2006 Jan; 12(4):636-9. PubMed ID: 16489682
[TBL] [Abstract][Full Text] [Related]
9. The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
Baskaran UL; Sabina EP
Cell Biol Toxicol; 2015 Oct; 31(4-5):211-9. PubMed ID: 26374116
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.
Lian Y; Zhao J; Xu P; Wang Y; Zhao J; Jia L; Fu Z; Jing L; Liu G; Peng S
PLoS One; 2013; 8(8):e72058. PubMed ID: 23967274
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective activity of Tamarindus indica Linn stem bark ethanolic extract against hepatic damage induced by co-administration of antitubercular drugs isoniazid and rifampicin in Sprague Dawley rats.
Meena SZ; Rahman MA; Bagga P; Mujahid M
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):131-137. PubMed ID: 30179850
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective activity of hepatoplus on isonaizid and rifampicin induced hepatotoxicity in rats.
Sankar M; Rajkumar J; Devi J
Pak J Pharm Sci; 2015 May; 28(3):983-90. PubMed ID: 26004706
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.
Sarich TC; Adams SP; Petricca G; Wright JM
J Pharmacol Exp Ther; 1999 May; 289(2):695-702. PubMed ID: 10215642
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
Saad EI; El-Gowilly SM; Sherhaa MO; Bistawroos AE
Food Chem Toxicol; 2010 Jul; 48(7):1869-75. PubMed ID: 20417245
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
Yue J; Peng RX; Yang J; Kong R; Liu J
Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN
Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703
[TBL] [Abstract][Full Text] [Related]
18. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
[TBL] [Abstract][Full Text] [Related]
19. A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats.
Sabina EP; Peter S J; S P; Geetha A
J Histotechnol; 2019 Sep; 42(3):128-136. PubMed ID: 31379302
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
Labana S; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]